Comprehensive Study Guide to Glycogen Metabolism: Synthesis, Degradation, Regulation, and Clinical Pathology
Molecular Mechanisms of Glycogen Synthesis
Conversion of Glucose-6-Phosphate to Glucose-1-Phosphate
The initial step in glycogen synthesis involves the isomerization of Glucose-6-phosphate () to Glucose-1-phosphate ().
This reaction is catalyzed by the enzyme phosphoglucomutase.
The chemical structures involved are:
Glucose-6-phosphate: A glucose ring with a phosphate group attached to the group at position 6.
Glucose-1-phosphate: A glucose ring with the phosphate group attached to the oxygen at position 1.
Activation of Glucose-1-Phosphate
To be added to a glycogen chain, must be activated.
This process requires Uridine Triphosphate (UTP) and is catalyzed by the enzyme UDP-glucose pyrophosphorylase.
The reaction proceeds as follows:
The byproduct, inorganic pyrophosphate (), is immediately hydrolyzed into two inorganic phosphates () by the enzyme inorganic pyrophosphatase. This hydrolysis renders the synthesis of UDP-glucose irreversible.
Glycogen Chain Extension and Branching
Two primary enzymes are responsible for the addition of glucose units to the glycogen molecule:
Glycogen synthase: This enzyme creates linkages. It transfers a glucose residue from UDP-glucose to the non-reducing end of a glycogen core, releasing UDP.
Amylo-\alpha(1,4 \rightarrow 1,6)-glucosyltransferase (Branching enzyme): This enzyme forms linkages. It removes a string of glucose residues from a chain and reattaches them via an bond to create a branch point.
The process of chain extension and branching allows the core to expand from multiple non-reducing ends simultaneously.
Energetics of Glycogen Synthesis
Starting from free glucose, the process consumes two high-energy phosphate bonds per glucose residue added:
Hexokinase: Initial phosphorylation of glucose to .
UDP-glucose pyrophosphorylase: Utilization of UTP.
Total energy cost: equivalents per residue.
Biochemistry of Glycogen Breakdown (Glycogenolysis)
The Phosphorolysis Process
Glycogen breakdown is an energy-efficient process that requires no initial ATP investment.
Glucose units are removed one at a time from the non-reducing ends of the glycogen polymer.
The process uses inorganic phosphate () and the enzyme glycogen phosphorylase.
The resulting product is glucose-1-phosphate (Gluc-1-P).
Constraint: Glycogen phosphorylase can only cleave glycosidic linkages.
Debranching Mechanism
Because phosphorylase cannot break bonds at branch points, a debranching enzyme is required.
This enzyme has two distinct activities:
Transferase: Moves a block of three glucose residues from one outer branch to another, exposing the single glucose residue attached by an bond.
\alpha-1,6-Glucosidase: Hydrolyzes the linkage, releasing a free glucose molecule.
Energetics of Glycogen Utilization
Aerobic conditions (Muscle): Conversion to leads to Glycolysis and then the Citric Acid Cycle (CAC).
Anaerobic conditions (Muscle): Conversion to leads to Glycolysis, resulting in the production of Lactate.
Allosteric and Covalent Regulation of Glycogen Phosphorylase
Structural Forms of Phosphorylase
Phosphorylase a: The phosphorylated form, which is typically active.
Phosphorylase b: The dephosphorylated form, which is typically inactive.
Both forms exist in an equilibrium between the R (Relaxed/Active) state and the T (Tense/Inactive) state.
Organ-Specific Allosteric Regulation
In the Liver: The primary role is maintaining blood glucose. In the liver, Phosphorylase a is regulated by glucose levels. When glucose binds to the enzyme, it promotes the transition from the active R state to the inactive T state.
In the Muscle: The primary role is providing energy for contraction. Phosphorylase b is regulated by the energy charge of the cell:
AMP: High levels of AMP (signaling low energy) bind to nucleotide-binding sites and promote the transition from the T state to the active R state.
ATP and Glucose-6-phosphate: High levels of these molecules (signaling high energy) inhibit the enzyme, favoring the T state.
The Role of Phosphorylase Kinase
Phosphorylase kinase is responsible for converting Phosphorylase b into Phosphorylase a via phosphorylation.
It is a complex enzyme () regulated by two main signals:
Calcium Ions (): Calcium binds to the subunit (calmodulin). This occurs during nerve impulses and muscle contraction, providing partial activation.
Phosphorylation: Protein Kinase A (PKA) phosphorylates the enzyme in response to hormones, leading to full activation.
Hormonal Control and Signal Transduction Pathways
Hormone Functions
Insulin: Promotes glycogen synthesis after a meal.
Glucagon (Liver): Promotes glycogen degradation to increase blood sugar levels during fasting.
Epinephrine (Muscle and Liver): Promotes glycogen degradation during exercise or "fight or flight" responses.
The Signal Cascade for Degradation
Binding of Glucagon or Epinephrine to a 7TM receptor activates a Trimeric G protein.
The G protein ( subunit) activates Adenylate cyclase, which converts ATP to Cyclic AMP (cAMP).
cAMP activates Protein Kinase A (PKA).
PKA performs a dual regulatory role:
It phosphorylates and activates Phosphorylase kinase, which subsequently phosphorylates and activates Phosphorylase b to Phosphorylase a.
It phosphorylates Glycogen synthase, converting it from the active 'a' form to the inactive 'b' form (Glycogen synthase kinase also participates in this inactivation).
Regulation After a Meal or at Rest
Glycogen synthesis must be stimulated while breakdown is inhibited.
Protein Phosphatase 1 (PP1) plays a central role by removing phosphate groups.
PP1 dephosphorylates:
Phosphorylase kinase (inactivating it).
Phosphorylase a (converting it to inactive Phosphorylase b).
Glycogen synthase b (converting it to active Glycogen synthase a).
Insulin Signaling Pathway
Insulin binds to its receptor, leading to the phosphorylation of Insulin Receptor Substrates (IRS).
This activates protein kinases that phosphorylate and inactivate Glycogen Synthase Kinase.
Inactivation of the kinase, combined with the action of PP1, shifts the equilibrium toward the active Glycogen synthase a.
Table 25.1: Clinical Correlates (Glycogen-Storage Diseases)
Type | Disease Name | Defective Enzyme | Organ Affected | Glycogen Status | Clinical Features |
|---|---|---|---|---|---|
I | von Gierke disease | Glucose 6-phosphatase or transport system | Liver and kidney | Increased amount; normal structure | Massive liver enlargement; Failure to thrive; Severe hypoglycemia, ketosis, hyperuricemia, hyperlipemia. |
II | Pompe disease | (lysosomal) | All organs | Massive increase in amount; normal structure | Cardiorespiratory failure cause death, usually before age 2. |
III | Cori disease | (debranching enzyme) | Muscle and liver | Increased amount; short outer branches | Like type I, but milder course. |
IV | Andersen disease | Branching enzyme () | Liver and spleen | Normal amount; very long outer branches | Progressive cirrhosis of the liver; Liver failure causes death, usually before age 2. |
V | McArdle disease | Phosphorylase | Muscle | Moderately increased amount; normal structure | Limited ability to perform strenuous exercise due to painful muscle cramps. Otherwise normal. |
VI | Hers disease | Phosphorylase | Liver | Increased amount | Like type I, but milder course. |
VII | Tarui disease | Phosphofructokinase | Muscle | Increased amount; normal structure | Like type V. |
VIII | -- | Phosphorylase kinase | Liver | Increased amount; normal structure | Mild liver enlargement; Mild hypoglycemia. |
Inheritance Notes:
Types I through VII are inherited as autosomal recessives.
Type VIII is sex-linked.